Co-Infection as a Risk Factor in COVID-19 Mortality Rate
DOI:
https://doi.org/10.51984/joms.v17i1.2044Keywords:
Covid-19 coinfection, nosocomial pathogen, MDR, Superbug organism, RT-PCR, gram-negative sepsis, multidrug antibiotic resistance, mortalityAbstract
The Antibiotics are not used to treat infectious disease caused by viruses, but it can also be prescribed for treating the infections caused by bacteria. The patient on ventilation is at risk for nosocomial pathogen and they need an urgent antibiotic intervention. In this study we aimed to find out the etiologies of secondary bacterial infection and the clinical outcome of COVID-19 patients admitted to isolation department, Sebha Medical Center (SMC). Eight patients (8/50) showed increased the inflammatory markers after 48hrs of admission. The antibiotic culture sensitivity profile showed that the gram-negative bacteria (Pseudomonas spp., Acinetobacter bumannii, Stenotrophomonas maltophil) were the predominant. 2/8 of the critically ill patient were improved and home discharged. The remaining (6/8) was deteriorated due to multidrug resistant bacteria infection and they did not receive the appropriate antibiotics.
Downloads
Downloads
Published
License
Copyright (c) 2022 Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This article is published open access under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). You may copy, redistribute, adapt and build upon it for non-commercial purposes, provided you credit the authors, cite the original publication in the Journal of Medical Sciences with its DOI, indicate any changes, and distribute any adaptations under the same licence. Copyright rests with the authors. For commercial reuse, please contact the corresponding author. Full terms: https://sebhau.edu.ly/journal/joms/copyright-licensing
